Business
Viz.ai Announces Strategic Collaboration to Expand Access to AI-Powered Subdural Hemorrhage Care
SAN FRANCISCO, April 23, 2026--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a strategic commercialization collaboration with Johnson & Johnson to expand access to Viz.ai’s Subdural Hemorrhage software solution across hospitals in the United States for automated detection, labeling and quantification of subdural collections. By integrating the Viz Subdural solution into its neurovascular offerings, the company aims to support hospitals in i
About this update from Johnson & Johnson
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/115ced45f0faa295931e9e75bd83752d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Gwnldl0uUz2qFQFKNjgJPQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk2MA--/https://media.zenfs.com/en/business-wire.com/115ced45f0faa295931e9e75bd83752d","width":480,"height":480}},"lazy":false},{"type":"text","content":"Collaboration advances coordinated care for patients with chronic subdural hematoma","length":83,"tagName":"p","attribs":{}},{"type":"text","content":"SAN FRANCISCO, April 23, 2026--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a strategic commercialization collaboration with Johnson & Johnson to expand access to Viz.ai’s Subdural Hemorrhage software solution across hospitals in the United States for automated detection, labeling and quantification of subdural collections. By integrating the Viz Subdural solution into its neurovascular offerings, the company aims to support hospitals in identifying appropriate patients and streamlining care pathways for suspected chronic subdural hematoma (cSDH), from detection through treatment and follow-up.","length":679,"tagName":"p"},{"type":"text","content":"The Viz Subdural solution includes FDA 510(k)-cleared algorithms for the detection of subdural hemorrhage, and automated labeling, visualization, and quantification of collections in the subdural space. The solution is powered by the Viz.ai platform, including Viz Assist, which provides AI-driven chart summarization to help clinicians quickly contextualize imaging findings within the broader clinical picture. By surfacing relevant patient history, medications, and prior notes, Viz Assist is intended to reduce manual chart review and accelerate clinical decision-making, enabling faster, more informed care coordination.","length":625,"tagName":"p"},{"type":"text","content":""Chronic subdural hematoma is a growing condition with a novel therapeutic procedure, MMA embolization, that has been proven effective," said Chris Mansi, MD, CEO and co-founder of Viz.ai. "By collaborating with Johnson & Johnson, we are expanding access to AI-powered detection and coo...